AU2001283344A1 - Dermatological formulation - Google Patents

Dermatological formulation

Info

Publication number
AU2001283344A1
AU2001283344A1 AU2001283344A AU8334401A AU2001283344A1 AU 2001283344 A1 AU2001283344 A1 AU 2001283344A1 AU 2001283344 A AU2001283344 A AU 2001283344A AU 8334401 A AU8334401 A AU 8334401A AU 2001283344 A1 AU2001283344 A1 AU 2001283344A1
Authority
AU
Australia
Prior art keywords
dermatological formulation
dermatological
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283344A
Inventor
Keith Arthur Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001283344A1 publication Critical patent/AU2001283344A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
AU2001283344A 2000-08-14 2001-08-13 Dermatological formulation Abandoned AU2001283344A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22532800P 2000-08-14 2000-08-14
US60225328 2000-08-14
PCT/US2001/025334 WO2002013868A1 (en) 2000-08-14 2001-08-13 Dermatological formulation

Publications (1)

Publication Number Publication Date
AU2001283344A1 true AU2001283344A1 (en) 2002-02-25

Family

ID=22844446

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283344A Abandoned AU2001283344A1 (en) 2000-08-14 2001-08-13 Dermatological formulation

Country Status (5)

Country Link
EP (1) EP1309351A1 (en)
JP (1) JP2004506023A (en)
AR (1) AR032362A1 (en)
AU (1) AU2001283344A1 (en)
WO (1) WO2002013868A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
FR2850276B1 (en) * 2003-01-23 2005-03-04 Louis Gerald Alcindor ANTI-EXCESSING AND / OR ANTI-DESQUAMANT AND / OR ANTI-EXFOLIANT COMPOSITION
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
WO2007070423A2 (en) * 2005-12-09 2007-06-21 Nycomed Us Inc. Topical glucocorticosteroid formulations
FR2898498B1 (en) * 2006-03-15 2008-11-28 Galderma Sa NOVEL TOPIC COMPOSITIONS IN THE FORM OF O / W EMULSION COMPRISING PRO-PENETRANT GLYCOL
JP2011045316A (en) * 2009-08-28 2011-03-10 T Hasegawa Co Ltd Triacetin-mixed oil-in-water type emulsion composition
FR2970175B1 (en) * 2011-01-10 2013-07-26 Oreal PROCESS FOR COLORING OR LIGHTENING TWO-PIECE KERATIN FIBERS USING DIRECT OIL-RICH EMULSION BASED ON SOLID FATTY ALCOHOL AND DIFFERENT OILS OF POLARITY.
FR2970176B1 (en) * 2011-01-10 2015-01-02 Oreal PROCESS FOR COLORING OR LIGHTENING TWO-PART KERATIN FIBERS FROM OIL-RICH DIRECT ALKALINE EMULSION BASED ON SOLID NON-IONIC SURFACTANT OF HLB RANGING FROM 1.5 TO 10
FR2970173B1 (en) * 2011-01-10 2013-07-05 Oreal COLORING OR LIGHTENING PROCESS USING A RICH BODY COMPOSITION COMPRISING A SOLID ALCOHOL AND ESTER, COMPOSITIONS AND DEVICE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103764D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Compositions
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity

Also Published As

Publication number Publication date
JP2004506023A (en) 2004-02-26
EP1309351A1 (en) 2003-05-14
AR032362A1 (en) 2003-11-05
WO2002013868A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001294192A1 (en) Solid preparations
AU7860201A (en) Dermatological composition
AU2001295657A1 (en) Formulation containing wax-esters
AU2001262691A1 (en) Cosmetic preparation
AU2002257582A1 (en) Pharmaceutical formulation
AU2001259702A1 (en) Tissue regrafting
AU2001263839A1 (en) Liquid formulations
AU2001293728A1 (en) Cosmetic composition
AU2001248215A1 (en) Cosmetically active composition
AU2001233208A1 (en) Human sulfatases
AU2002255692A1 (en) A cream-t0-powder dermatological composition
AU2001290239A1 (en) Medicinal composition
AU2001283344A1 (en) Dermatological formulation
AU2001286400A1 (en) Fiber formulation
GB0111314D0 (en) Dermatological formulations
AU2002227925A1 (en) Human beta-defensin-3
AU2002345278A1 (en) Herbal formulation
AU2002345276A1 (en) Herbal formulation
AU2001288102A1 (en) Solid preparations
AU2001231089A1 (en) Complete meal formulation
AU2001282521A1 (en) OCT preparations
AUPR099200A0 (en) New formulation
AU2000238755A1 (en) Dermatological compounds
AU2001280310A1 (en) Cosmetic cream
AU2001272427A1 (en) Solid preparations